Moderna (MRNA) options began trading for the November 20 expiration, with 156 days remaining until expiry. The article is primarily a market-structure update about new derivative contracts rather than a company-specific fundamental development. Any price impact is likely limited and mostly tied to options positioning and implied volatility.
Moderna (MRNA) options began trading for the November 20 expiration, with 156 days remaining until expiry. The article is primarily a market-structure update about new derivative contracts rather than a company-specific fundamental development. Any price impact is likely limited and mostly tied to options positioning and implied volatility.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment